Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Julia Laurin
Medication Adherence

Bud Bilanich
Success Coach

Don Feiler
Brand Engagement

Lillie D. Shockney, RN, BS, MAS, HON- ONN-CG
The Treatment Experience

Devin Kanach
Non-Personal Promotion

Ira Haimowitz
Closed-Loop Marketing

Aaron Davis
Value & Access

David Linetsky
Point-of-Care Marketing

Adrienne Stevens, EdD, MBA
HCP Insights

Sarah Caldwell
Data & Analytics

Brenda Snow
Authentic Patient Voice

Ed Cohen, PharmD, FAPhA
Pharmacy’s Significance